Effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure

Joost C. Beusekamp; Jasper Tromp; Eva M. Boorsma; Hiddo J. L. Heerspink; Kevin Damman; Adriaan A. Voors; Peter van der Meer

doi:10.1002/ejhf.2197

Effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure

Joost C. Beusekamp, Jasper Tromp, Eva M. Boorsma, Hiddo J. L. Heerspink, Kevin Damman, Adriaan A. Voors, Peter van der Meer^*

^*Bijbehorende auteur voor dit werk

Onderzoeksoutput › Academic › peer review

1 Citaat (Scopus)

44 Downloads (Pure)

Originele taal-2	English
Pagina's (van-tot)	1049–1052
Aantal pagina's	4
Tijdschrift	European Journal of Heart Failure
Volume	23
Nummer van het tijdschrift	6
Vroegere onlinedatum	11-mei-2021
DOI's	https://doi.org/10.1002/ejhf.2197
Status	Published - jun.-2021

Toegang tot document

10.1002/ejhf.2197Licentie: CC BY-NC-ND

Effects of sodium–glucose co-transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failureFinal publisher's version, 162 KBLicentie: CC BY-NC-ND

Handle.net

Permanente koppeling

Citeer dit

@article{741e25008ba74067ab91e0a5942220eb,

title = "Effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure",

keywords = "DAPAGLIFLOZIN, RISK",

author = "Beusekamp, {Joost C.} and Jasper Tromp and Boorsma, {Eva M.} and Heerspink, {Hiddo J. L.} and Kevin Damman and Voors, {Adriaan A.} and {van der Meer}, Peter",

year = "2021",

month = jun,

doi = "10.1002/ejhf.2197",

language = "English",

volume = "23",

pages = "1049–1052",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "Wiley",

number = "6",

}

TY - JOUR

T1 - Effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure

AU - Beusekamp, Joost C.

AU - Tromp, Jasper

AU - Boorsma, Eva M.

AU - Heerspink, Hiddo J. L.

AU - Damman, Kevin

AU - Voors, Adriaan A.

AU - van der Meer, Peter

PY - 2021/6

Y1 - 2021/6

KW - DAPAGLIFLOZIN

KW - RISK

U2 - 10.1002/ejhf.2197

DO - 10.1002/ejhf.2197

M3 - Letter

SN - 1388-9842

VL - 23

SP - 1049

EP - 1052

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

IS - 6

ER -